Conversation

But 5 years after the UK’s exit from the EU, the most comprehensive analysis of its kind concludes that while patients across Europe are benefiting frm a golden age of pioneering research and novel treatments, Britons w/cancer have “lost out” thanks to rising prices and red tape.

Brexit has “damaged the practical ability” of docs to offer NHS patients life-saving new drugs via intnl clinical trials, according to the 54 pg report obtained by the Guardian.

RACISM KILLS

https://www.theguardian.com/science/2025/apr/20/nhs-cancer-patients-denied-life-saving-drugs-due-to-brexit-costs-report-finds